- Cell Therapy Clinical Trials: Navigating the operational shift from Phase 1 to Phase 2Posted 16 hours ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 14, 2017Posted 4 days ago
- GMP Proteins for Cell Therapy Manufacturing: Top 6 Things to KnowPosted 5 days ago
- Smart Cell Culture Monitoring – Transforming the way we look at cells in culturePosted 6 days ago
- A Primer on Primary Cells and CulturePosted 7 days ago
- The Importance of Resin Selection in Development of a Platform Bioprocess FilmPosted 1 week ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 7, 2017Posted 2 weeks ago
- Is Automation the Disruption Pharma R&D Needs?Posted 2 weeks ago
- Job Outlook for the Biomanufacturing IndustryPosted 2 weeks ago
- Development of a Chemically-defined, Animal Component-free Medium for T cell CulturePosted 2 weeks ago
More Industry Issues News
Recent Legislation a Boost for Biosimilars?
Biosimilars, also known as “follow on biologics,” are copies of currently marketed biopharmaceuticals. After...
- Posted April 22, 2011
Finding an Intellectual Property Balance with Stem Cell Research
There are several challenges with protecting intellectual property (IP) in stem cell research. A...
- Posted April 7, 2011
Commercial Stem Cell Therapies
There are indeed several stem cell and regenerative medicine therapies that are already on...
- Posted March 29, 2011
The Regulatory Future of Stem Cell Therapies is yet to be Determined
The stem cell therapy market appears to have a bright future and recent stem...
- Posted March 25, 2011